Wolf A - Search Results

1

Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.

Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C. Kook D, et al. Among authors: wolf a. Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48. Retina. 2008. PMID: 18779710

2

[Central pigment epithelial defect in a 33 year-old female patient. A 33 year-old female patient with neurological symptoms, central pigment epithelial defect and limited upward gaze].

Wolf AH, Gass C, Kampik A, Rudolph G. Wolf AH, et al. Ophthalmologe. 2004 Aug;101(8):841-2. doi: 10.1007/s00347-003-0921-0. Ophthalmologe. 2004. PMID: 15459793 German. No abstract available.

3

[Clinical aspects of retinopathy of prematurity. Results following diode laser coagulation].

Rudolph G, Buhl M, Pietschmann M, Wolf A, Priglinger S, Boergen KP, Kampik A. Rudolph G, et al. Among authors: wolf a. Klin Monbl Augenheilkd. 2006 Jun;223(6):528-33. doi: 10.1055/s-2005-859020. Klin Monbl Augenheilkd. 2006. PMID: 16804824 German.

4

[Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].

Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW. Kook D, et al. Among authors: wolf a. Ophthalmologe. 2008 Feb;105(2):158-64. doi: 10.1007/s00347-007-1561-6. Ophthalmologe. 2008. PMID: 17653552 German.

5

Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.

Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, Kunze C, Haritoglou C, Kampik A, Priglinger S. Kreutzer TC, et al. Among authors: wolf ah. Br J Ophthalmol. 2008 Mar;92(3):351-5. doi: 10.1136/bjo.2007.123513. Epub 2008 Jan 22. Br J Ophthalmol. 2008. PMID: 18211925 Free article. Clinical Trial.

6

[Anti-VEGF treatment for retinal angiomatous proliferation].

Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A, Ulbig M. Wolf A, et al. Ophthalmologe. 2008 Sep;105(9):845-51. doi: 10.1007/s00347-008-1785-0. Ophthalmologe. 2008. PMID: 18607601 German.

7

How to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis?

Wolf A, Kook D, Strauss R, Kampik A, Haritoglou C. Wolf A, et al. Br J Ophthalmol. 2008 Sep;92(9):1298-9. doi: 10.1136/bjo.2008.138396. Br J Ophthalmol. 2008. PMID: 18723750 No abstract available.

8

[Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium].

Kernt M, Hirneiss C, Neubauer AS, Lackerbauer CA, Eibl KH, Wolf A, Ulbig M, Kampik A. Kernt M, et al. Among authors: wolf a. Ophthalmologe. 2010 Feb;107(2):150-7. doi: 10.1007/s00347-009-1945-x. Ophthalmologe. 2010. PMID: 19499230 German.

9

[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].

Kernt M, Hirneiss C, Neubauer AS, Liegl RG, Eibl KH, Wolf A, de Kaspar H, Ulbig MW, Kampik A. Kernt M, et al. Among authors: wolf a. Ophthalmologe. 2010 Aug;107(8):720-7. doi: 10.1007/s00347-009-2027-9. Ophthalmologe. 2010. PMID: 19756636 German.

10

[Volume calculations for current intravitreal injections of Lucentis].

Wolf A, Gandorfer A, Haritoglou C, Koller C, Thalmeier A, Kampik A. Wolf A, et al. Ophthalmologe. 2010 May;107(5):435-8. doi: 10.1007/s00347-009-2060-8. Ophthalmologe. 2010. PMID: 19838710 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,364 results

Search Page

Filters